Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6769-6784
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6769
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6769
Number of patients | Prevalence PVT, n (%) | PVT characteristics | Outcomes | |
Englesbe et al[65] | 22291 (2001-2007) | 897 (4.02) | Not described | PVT was not predictive of waiting list mortality (HR = 0.90, P = 0.23) |
PVT was predictive of post-transplant mortality (HR = 1.32, P = 0.02) | ||||
Sringeri et al[61] | 1491 (2000-Aug 2012) | 119 (8.0) | Not described | Prolonged theatre timea, increased blood transfusion rates1. No difference mortality up-to 140 mo |
Ravaioli et al[13] | 889 (1998-2008) | 91 (10.2) | Partial 51 (56%) | No difference 1 yr (85% vs 86%) and 5 yr (68% vs 73%) survival between PVT and non-PVT subjects |
Complete 40 (44%) | Survival improved significantly for patients with complete PVT in the second era (2003-2008) (57% vs 89% at 1 yr1) | |||
Yerdel et al[15] | 779 (1987-1996) | 63 (8.1) | Grade 1: 24, | Reduced 5 yr survival between PVT and non-PVT subjects (65.3% vs 76.3%1) |
Grade 2: 23, | ||||
Grade 3: 6, | But improved 5 yr survival from 1st to 2nd era in all patients (from 72% to 83%1) | |||
Grade 4: 10 |
- Citation: Harding DJ, Perera MTP, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21(22): 6769-6784
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6769.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6769